Connect with us

Hi, what are you looking for?

AI Regulation

Bipartisan Effort Blocks AI Regulation Ban in Defense Bill, Scalise Seeks Alternative Path

Bipartisan opposition halts a proposed ban on state AI regulations in defense legislation, as Scalise seeks alternative routes amid rising calls for consumer safety.

The push to prohibit states from regulating artificial intelligence (AI) within the framework of a defense bill has been rejected, facing bipartisan opposition. House Majority Leader Steve Scalise (R-LA) announced on Tuesday that Republican leaders would explore “other places” to amend the legislation, a move that has garnered support from former President Donald Trump, as reported by The Hill.

This proposal to preempt state-level AI regulations came several months after Republican lawmakers attempted to insert a decade-long moratorium on such laws into a tax and spending bill associated with Trump. That effort also failed amid strong resistance from both sides of the aisle.

Supporters in Silicon Valley have advocated for these measures, arguing that varying state regulations create an unmanageable patchwork of rules that could hinder innovation. However, critics contend that much of the state-level AI legislation is aimed at enhancing safety, transparency, and consumer protection. They warn that blocking states from imposing regulations would effectively cede control to Big Tech without any oversight, leaving consumers vulnerable.

Scalise acknowledged that the defense bill was not the appropriate venue for such a contentious provision and reiterated Trump’s earlier calls to pursue the ban through separate legislation. In parallel, a leaked draft of an executive order indicates that Trump is contemplating unilateral action, although those plans appear to be on hold for now.

The ongoing debate highlights the complexities and challenges of regulating AI technology in a rapidly evolving landscape. With significant advancements in AI capabilities, the urgency for appropriate oversight has grown, prompting various stakeholders to seek clarity on regulatory frameworks.

As discussions continue, the implications of AI regulation remain profound. The balance between fostering innovation and ensuring consumer safety will be a focal point of future legislative efforts. The rejection of this particular measure does not signify the end of the conversation; rather, it underscores the necessity for a more comprehensive approach to AI governance that can unite diverse perspectives across the political spectrum.

See also
Staff
Written By

The AiPressa Staff team brings you comprehensive coverage of the artificial intelligence industry, including breaking news, research developments, business trends, and policy updates. Our mission is to keep you informed about the rapidly evolving world of AI technology.

You May Also Like

AI Generative

Generative AI achieves over 85% accuracy in predicting mental health treatment success, marking a pivotal shift toward Precision Psychiatry with $10 billion market potential...

Top Stories

Anthropic shares soar amid a frenzy of offers exceeding $1 trillion, as investors compete aggressively for stakes in the AI powerhouse.

AI Government

Pentagon partners with Google to enhance AI use in classified operations, shifting from Anthropic amid employee protests over civil liberties concerns.

AI Research

U.S. AI investments surge to $10B, driving deep learning and HCI innovations as companies like Google and OpenAI reshape career paths for tech professionals.

Top Stories

DeepSeek's V4-Pro eclipses GPT-5 and Claude in key benchmarks, achieving a Codeforces rating of 3,206 while undercutting OpenAI's costs by 89% per million tokens.

AI Technology

AI-generated content skyrockets as TikTok users upload over 1.3 billion AI-created videos, raising urgent concerns over authenticity and content integrity.

AI Regulation

Oklahoma City bans AI data centers until year-end, joining 11 states in imposing restrictions as Trump's federal framework aims to limit state regulations.

Top Stories

FDA fast-tracks psilocybin and methylone reviews with national priority vouchers, slashing approval timelines to just 1-2 months for breakthrough mental health treatments.

© 2025 AIPressa · Part of Buzzora Media · All rights reserved. This website provides general news and educational content for informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the information presented. The content should not be considered professional advice of any kind. Readers are encouraged to verify facts and consult appropriate experts when needed. We are not responsible for any loss or inconvenience resulting from the use of information on this site. Some images used on this website are generated with artificial intelligence and are illustrative in nature. They may not accurately represent the products, people, or events described in the articles.